(Q39907289)

15 September 2017

title

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung (English)

1 reference

15 September 2017

1 reference

1 reference

5

1 reference

15 September 2017

Tatjana M H Niers

1

1 reference

15 September 2017

Lois W Brüggemann

2

1 reference

15 September 2017

Clara P W Klerk

3

1 reference

15 September 2017

Femke J M Muller

4

1 reference

15 September 2017

Pieter H Reitsma

6

1 reference

15 September 2017

Dick J Richel

7

1 reference

15 September 2017

C Arnold Spek

8

1 reference

15 September 2017

Olaf Van Tellingen

9

1 reference

15 September 2017

Cornelis J F Van Noorden

10

1 reference

15 September 2017

publication date

10 December 2008

1 reference

Clinical & Experimental Metastasis

15 September 2017

published in

1 reference

15 September 2017

volume

26

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

171-178

1 reference

Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo

15 September 2017

cites work

1 reference

12 December 2020

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

12 December 2020

The complex effects of heparins on cancer progression and metastasis in experimental studies.

1 reference

12 December 2020

Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms

1 reference

12 December 2020

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

1 reference

12 December 2020

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

12 December 2020

Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies

1 reference

12 December 2020

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

1 reference

12 December 2020

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents

1 reference

12 December 2020

Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma

1 reference

12 December 2020

Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation

1 reference

12 December 2020

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

1 reference

12 December 2020

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

12 December 2020

Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver

1 reference

12 December 2020

Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix

1 reference

12 December 2020

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

1 reference

12 December 2020

Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis

1 reference

12 December 2020

Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals

1 reference

12 December 2020

Mechanisms of heparin induced anti-cancer activity in experimental cancer models

1 reference

12 December 2020

Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line.

1 reference

12 December 2020

Tissue factor pathway inhibitor and the revised theory of coagulation

1 reference

12 December 2020

Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo

1 reference

12 December 2020

Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines

1 reference

12 December 2020

Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation

1 reference

12 December 2020

Fibrin as a component of the tumor stroma: origins and biological significance

1 reference

12 December 2020

Thrombin receptor overexpression in malignant and physiological invasion processes

1 reference

12 December 2020

Mechanisms of action of proteinase-activated receptor agonists on human platelets

1 reference

12 December 2020

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

1 reference

12 December 2020

Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders

1 reference

12 December 2020

Coagulant activity of leukocytes. Tissue factor activity

1 reference

12 December 2020

P-selectin deficiency attenuates tumor growth and metastasis

1 reference

12 December 2020

The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

1 reference

12 December 2020

Human Protease-Activated Receptor 1 Expression in Malignant Epithelia

1 reference

12 December 2020

Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

1 reference

12 December 2020

Cancer and thrombosis: from molecular mechanisms to clinical presentations

1 reference

12 December 2020

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

12 December 2020

Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer

1 reference

12 December 2020

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

12 December 2020

Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface

1 reference

12 December 2020

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro

1 reference

12 December 2020

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

1 reference

12 December 2020

Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects

1 reference

12 December 2020

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

1 reference

12 December 2020

Metastasis results from preexisting variant cells within a malignant tumor

1 reference

12 December 2020

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity

1 reference

12 December 2020

10.1007/S10585-008-9227-6

Identifiers

DOI

1 reference

15 September 2017

1 reference